TOP 100:
News on
in
for

Science & Education

December 18, 2014 14:00
KIEV, Ukraine--(BUSINESS WIRE)--Enamine Ltd, a leading provider of screening compounds, chemical building blocks and discovery services, has announced that it has extended its collaboration agreement with Sanofi, an integrated global healthcare leader. Based on the success of the collaboration to...
World  World      Research  Research
December 18, 2014 14:00
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Global Genes™ Partners with Genetic Disorders UK to Empower Individuals and Families affected by Rare Genetic Disorders Globally. Rare genetic disorders affect 1 in 25 children born in the UK
World  World      Research  Research
December 18, 2014 14:00
KIEV, Ucraina--(BUSINESS WIRE)--Enamine Ltd, un importante fornitore di composti per screening, blocchi per la costruzione chimica e servizi di scoperta, ha annunciato di aver prolungato il suo accordo di collaborazione con Sanofi, leader globale nella sanità integrata. In base al successo che la...
World  World      Research  Research
December 18, 2014 14:00
KIEV, Ukraine--(BUSINESS WIRE)--Enamine Ltd, un important fournisseur de composés de discrimination, de synthons chimiques et de services de découverte, a annoncé qu’il a prolongé son entente de collaboration avec Sanofi, un leader mondial en soins de santé intégrés. Grâce au succès de la collabo...
World  World      Research  Research
December 18, 2014 14:00
KIEW, Ukraine--(BUSINESS WIRE)--Enamine Ltd, ein führender Anbieter von Dienstleistungen im Bereich Screening-Verbindungen, chemische Bausteine und Wirkstofffindung, meldete die Verlängerung seiner Kooperationsvereinbarung mit Sanofi, einem führenden integrierten, globalen Healthcare-Unternehmen....
World  World      Research  Research
December 18, 2014 13:47
费城--(BUSINESS WIRE)--(美国商业资讯) -- Ossianix, Inc.今天宣布扩大并延长与丹麦灵北制药公司(H. Lundbeck A/S)(简称“灵北”)的战略研究合作。此次合作之前的合作包括2012年的资产投资和2013年的研究合作。合作将采用Ossianix基于鲨鱼VNAR结构的创新单域抗体平台,以投放下一代CNS生物治疗药物。 Ossianix已开发了一种新型的、靶向作用于血脑屏障(BBB)的技术,用于投放生物治疗药物,包括治疗CNS障碍的抗体。凭借该协议的BBB平台技术部分,灵北能够调用一套受专利保护的跨物种反应VNAR工具,以实现按个体治疗需求定制产品...
World  World      Research  Research